Immediate Impact
3 from Science/Nature 65 standout
Citing Papers
Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline Update
2024 Standout
Molecular mechanisms in MASLD/MASH-related HCC
2024 Standout
Works of André Liem being referenced
Phase II Study of First-Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
2017
Phase II study of first-line trebananib plus sorafenib in patients with advanced hepatocellular carcinoma (HCC).
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| André Liem | 19 | 12 | 7 | 116 | 100 | 28 | 284 | |
| Cristiane Milito | 138 | 61 | 26 | 298 | ||||
| Riccardo Moia | 102 | 100 | 31 | 201 | ||||
| Meirav Kedmi | 144 | 50 | 31 | 269 | ||||
| Philip Ironside | 82 | 47 | 24 | 291 | ||||
| Subhayan Chattopadhyay | 104 | 66 | 36 | 309 | ||||
| Wenbin Qian | 104 | 26 | 40 | 279 | ||||
| Lourdes Cordón | 2 | 36 | 64 | 26 | 290 | |||
| Leyre Bento | 86 | 48 | 31 | 229 | ||||
| Lokanatha Dasappa | 1 | 44 | 40 | 36 | 233 | |||
| Maria Cristina Pirosa | 143 | 48 | 26 | 286 |
All Works
Login with ORCID to disown or claim papers
Loading papers...